Evaluation of Role of Ayurvedic Drug- Guduchi Ghan Vati in the treatment of COVID-19 related illness

Not Applicable

• Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

• Registration Number: CTRI/2020/05/025370
• Lead Sponsor: Dr SR Rajasthan Ayurved University Jodhpur

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.All hospitalized cases above 18-60 years of age, clinically diagnosed with corona virus disease 2019 (Covid19) and who are asymptomatic or having Mild symptoms.

2.Participants who can take medicines orally.

3.Patients willing to provide signed informed consent.

Exclusion Criteria

1.Cases of severe vomiting which would affect oral administration of medicine difficult.

2.Cases of respiratory failure and requiring mechanical ventilation.

3.Patients having Alanine Transaminase (ALT) or Aspartate Transaminase (AST) > 5 times the upper range of normal limits.

4.Patients with COVID-19 in critical condition or ARDS or NIAD 8 â??point ordinal score-2 (Hospitalized, on invasive mechanical Ventilation or extra corporeal membrane oxygenation

5.Combined organ failure requiring ICU monitoring.

6.Patients with uncontrolled Diabetes Mellitus, (HbA1c more than 8.0), Malignant Hypertension (systolic BP more than 180 and diastolic 110), Chronic Renal Failure and those on immunosuppressive medication.

7.Patients with history of malignancy, IHD, CAD, triple vessel disease, history of CABG, Stroke, etc.

8.Any other condition, which as per the investigator would jeopardize the outcome of the trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified